CAS RN: 53452-16-7

6-(2-O-alpha-L-Arabinopyranosyl-beta-D-glucopyranosyl)-2-[4-(beta-D-glucopyranosyloxy)phenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one

Product Availability

Choose a grade to view its available package options.

7 package records5 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260413 100mg Out of stock Inquiry
Batchno.20251223 10mg In stock Shanghai Inquiry
Batchno.20250308 1mg In stock Shanghai Inquiry
Batchno.20250428 25mg Out of stock Inquiry
Batchno.20250307 50mg In stock Shanghai Inquiry
Batchno.20250324 5mg In stock Shanghai Inquiry
Batchno.20250815 5mg / 25mg / 100mg Confirm by inquiry Shanghai, Shandong Inquiry
  • Product code: starshine_CAS53452-16-7
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

53452-16-7 / 6-[(2S,4S,5S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-[4-[(2S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one

Standard CAS: 53452-16-7 Multi CAS: Yes

Basic Information

CAS
53452-16-7
Multi CAS
Yes
Molecular Formula
C32H38O19
Molecular Weight
726.600000
Exact Mass
726.200729
InChI
InChI=1S/C32H38O19/c33-7-17-23(40)26(43)30(51-31-27(44)21(38)14(37)9-46-31)29(49-17)20-13(36)6-16-19(24(20)41)12(35)5-15(48-16)10-1-3-11(4-2-10)47-32-28(45)25(42)22(39)18(8-34)50-32/h1-6,14,17-18,21-23,25-34,36-45H,7-9H2/t14-,17+,18+,21-,22+,23+,25-,26-,27+,28+,29-,30+,31-,32+/m0/s1
InChIKey
GYIKGLVKALOGDP-HLEFUGOVSA-N

Computed Properties

Structural Parameters

Heavy atom count
51
Aromatic heavy atom count
16
Fraction Csp3
0.53
Rotatable bonds
8
H-bond acceptors
19
H-bond donors
12
Molar refractivity
164.99
TPSA
319.12

LogP / Solubility

WLOGP
-3.97
MLOGP
-3.43
XLogP3
-3.1
Consensus LogP
-3.5
Log S (ESOL)
-1.55
Class (ESOL)
Soluble
Log S (Ali)
-2.65
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.05
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-9.97

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us